134 related articles for article (PubMed ID: 19550404)
1. Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.
Horacek JM; Jebavy L; Jakl M; Zak P; Mericka P; Maly J
Exp Oncol; 2009 Jun; 31(2):121-2. PubMed ID: 19550404
[TBL] [Abstract][Full Text] [Related]
2. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
Ozdemir E; Akgedik K; Akdogan S; Kansu E
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
[TBL] [Abstract][Full Text] [Related]
3. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
[TBL] [Abstract][Full Text] [Related]
4. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
6. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
7. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age.
Milone G; Mercurio S; Strano A; Leotta S; Pinto V; Battiato K; Coppoletta S; Murgano P; Farsaci B; Privitera A; Giustolisi R
Cytotherapy; 2007; 9(4):348-55. PubMed ID: 17573610
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study.
López-Jiménez J; Cerveró C; Muñoz A; Hernández-Madrid A; Fernández Pineda J; García Laraña J; Moro C; Maldonado M; Pérez Oteyza J; Otheo E
Bone Marrow Transplant; 1994 Jun; 13(6):789-93. PubMed ID: 7920316
[TBL] [Abstract][Full Text] [Related]
9. Ischemic stroke associated with the infusion of DMSO-cryopreserved auto-PBSCs.
González-López TJ; Sánchez-Guijo FM; Ortín A; Crusoe E; Cordoba I; Corral M; Vazquez L; Caballero MD
Bone Marrow Transplant; 2011 Jul; 46(7):1035-6. PubMed ID: 20956954
[No Abstract] [Full Text] [Related]
10. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients.
Martino M; Morabito F; Messina G; Irrera G; Pucci G; Iacopino P
Haematologica; 1996; 81(1):59-61. PubMed ID: 8900855
[TBL] [Abstract][Full Text] [Related]
11. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
[TBL] [Abstract][Full Text] [Related]
12. Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion.
Júnior AM; Arrais CA; Saboya R; Velasques RD; Junqueira PL; Dulley FL
Bone Marrow Transplant; 2008 Jan; 41(1):95-6. PubMed ID: 17934528
[No Abstract] [Full Text] [Related]
13. Quantification of residual dimethylsulfoxide after washing cryopreserved stem cells and thawing tissue grafts.
Decot V; Houzé P; Stoltz JF; Bensoussan D
Biomed Mater Eng; 2009; 19(4-5):293-300. PubMed ID: 20042796
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing.
Calmels B; Houzé P; Hengesse JC; Ducrot T; Malenfant C; Chabannon C
Bone Marrow Transplant; 2003 May; 31(9):823-8. PubMed ID: 12732892
[TBL] [Abstract][Full Text] [Related]
15. Clinical side effects during peripheral blood progenitor cell infusion.
Donmez A; Tombuloglu M; Gungor A; Soyer N; Saydam G; Cagirgan S
Transfus Apher Sci; 2007 Feb; 36(1):95-101. PubMed ID: 17236813
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of autologous bone marrow graft infusion.
Davis J; Rowley SD; Santos GW
Prog Clin Biol Res; 1990; 333():531-40. PubMed ID: 2308999
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate.
Lemarie C; Calmels B; Malenfant C; Arneodo V; Blaise D; Viret F; Bouabdallah R; Ladaique P; Viens P; Chabannon C
Transfusion; 2005 May; 45(5):737-42. PubMed ID: 15847663
[TBL] [Abstract][Full Text] [Related]
18. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells.
Hoyt R; Szer J; Grigg A
Bone Marrow Transplant; 2000 Jun; 25(12):1285-7. PubMed ID: 10871734
[TBL] [Abstract][Full Text] [Related]
19. Adverse events of cryopreserved hematopoietic stem cell infusions in adults: a single-center observational study.
Otrock ZK; Sempek DS; Carey S; Grossman BJ
Transfusion; 2017 Jun; 57(6):1522-1526. PubMed ID: 28301051
[TBL] [Abstract][Full Text] [Related]
20. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
